For the detection of genes that were up/downregulated in prostate cancer cells remaining in bone following osteolytic tumor growth inhibition by OPG, a mixture containing equal amounts of PC3-GFP and either PC3-OPG or PC3-mock, was injected into the bones of nude mice. This evidence concerns the gene TNFRSF11B and prostate cancer.